GL1X · GenesisL1 explorer

MolNFT v1 · #171325 · protein

VEGF-a 13:107 crystallized with 3C bicyclic peptide

6Z13 · Bicyclic peptide 3C: “VEGF-a 13:107 crystallized with 3C bicyclic peptide”. X-ray diffraction, 1 ligand (NH2), 2 pockets (best druggability 0.34). MolNFT v1 #171325 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6Z13
Type
protein
Length
205 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bicyclic peptide 3C; Vascular endothelial growth factor a
UniProt
P15692
Ligands
NH2
Pockets
2 · best druggability 0.34

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
PBicyclic peptide 3Cprotein1520% helix, 0% strand—
V, WVascular endothelial growth factor aprotein9516% helix, 60% strandP15692

Ligands and binding sites

  • NH2 · Amino group · ion · chains P, V
  • ACY · Acetic acid · additive · 5 copies · chains V, W, P
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains V, W

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1970.340.7428empty
2690.340.7619empty

Interfaces

3 interfaces between chains.

  • V–W · 1401 Ų buried · 16 hydrogen bonds · protein-protein
  • P–W · 406 Ų buried · 6 hydrogen bonds · protein-protein
  • P–V · 172 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 9 disulfide, 1 isopeptide, 1 modified (disulfide, isopeptide, nonstandard).

Compared structures

  • 6Z13 · VEGF-A 13:107 crystallized with 3C bicyclic peptide · the same entry in another collection · chain P against P, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.